Aster DM Healthcare Ltd
BSE:540975

Watchlist Manager
Aster DM Healthcare Ltd Logo
Aster DM Healthcare Ltd
BSE:540975
Watchlist
Price: 684.35 INR 0.59% Market Closed
Market Cap: ₹340.6B

EV/EBIT

59.8
Current
87%
More Expensive
vs 3-y average of 32

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
59.8
=
Enterprise Value
₹338.3B
/
EBIT
₹6B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
59.8
=
Enterprise Value
₹338.3B
/
EBIT
₹6B

Valuation Scenarios

Aster DM Healthcare Ltd is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (32), the stock would be worth ₹365.54 (47% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-61%
Maximum Upside
No Upside Scenarios
Average Downside
49%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 59.8 ₹684.35
0%
3-Year Average 32 ₹365.54
-47%
5-Year Average 24 ₹274.35
-60%
Industry Average 42.5 ₹486.44
-29%
Country Average 23.3 ₹266.09
-61%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
₹338.3B
/
Jan 2026
₹6B
=
59.8
Current
₹338.3B
/
Mar 2026
₹6.6B
=
51.5
Forward
₹338.3B
/
Mar 2027
₹11.2B
=
30.3
Forward
₹338.3B
/
Mar 2028
₹14.6B
=
23.2
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

Higher than 88% of companies in India
Percentile
88th
Based on 2 572 companies
88th percentile
59.8
Low
0.4 — 15.7
Typical Range
15.7 — 34.7
High
34.7 —
Distribution Statistics
India
Min 0.4
30th Percentile 15.7
Median 23.3
70th Percentile 34.7
Max 48 145.1

Aster DM Healthcare Ltd
Glance View

Aster DM Healthcare Ltd. emerged from humble beginnings in 1987, founded by Dr. Azad Moopen, who envisioned a network that would deliver quality healthcare across varying geographies. What started with a single clinic in Dubai rapidly expanded into a sprawling healthcare conglomerate operating across multiple nations. Aster DM Healthcare's model rests on a comprehensive approach that includes hospitals, clinics, diagnostic centers, and pharmacies, providing an integrated continuum of care. This diversity is the essence of its operational strategy; ensuring patient needs are addressed at every touchpoint, be it an initial consultation at a clinic, diagnostics, specialized treatment, or the procurement of medications. The company's vast geographical footprint spans the Middle East, India, and beyond, tapping into regions where demand for accessible and quality healthcare continues to rise. This expansive portfolio allows Aster DM Healthcare to generate revenue through a variety of streams, capitalizing on its ability to cater to both the premium segment and more cost-sensitive patients. Hospitals and clinics serve as the primary engine for revenue, offering a range of services from routine health check-ups to complex surgeries. Diagnostics centers add an additional layer of profitability, catering to the growing demand for precise medical testing. Meanwhile, the pharmacy network expands the firm's reach beyond healthcare facilities, serving as a convenient healthcare touchpoint within communities. This multi-pronged approach not only maximizes revenue but also enhances overall operational resilience, ensuring that the company can weather market fluctuations and invest in technological advancements to improve patient care further.

ASTERDM Intrinsic Value
266.74 INR
Overvaluation 61%
Intrinsic Value
Price ₹684.35
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett